Tower Research Capital LLC (Trc) Replimune Group, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Replimune Group, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 457 shares of REPL stock, worth $2,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
457
Previous 6,772
93.25%
Holding current value
$2,399
Previous $82,000
95.12%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding REPL
# of Institutions
176Shares Held
78MCall Options Held
219KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$58 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$57 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA4.9MShares$25.7 Million5.02% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$24.7 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$20.5 Million9.21% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $259M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...